PDB Short entry for 1IRP
HEADER    CYTOKINE                                18-OCT-94   1IRP              
TITLE     SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN 
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: INTERLEUKIN-1 RECEPTOR ANTAGONIST;                         
COMPND   3 CHAIN: A;                                                            
COMPND   4 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606                                                 
KEYWDS    CYTOKINE                                                              
EXPDTA    SOLUTION NMR                                                          
NUMMDL    12                                                                    
AUTHOR    B.J.STOCKMAN,T.A.SCAHILL,N.A.STRAKALAITIS                             
REVDAT   4   23-FEB-22 1IRP    1       REMARK                                   
REVDAT   3   24-FEB-09 1IRP    1       VERSN                                    
REVDAT   2   01-APR-03 1IRP    1       JRNL                                     
REVDAT   1   27-FEB-95 1IRP    0                                                
JRNL        AUTH   B.J.STOCKMAN,T.A.SCAHILL,N.A.STRAKALAITIS,D.P.BRUNNER,       
JRNL        AUTH 2 A.W.YEM,M.R.DEIBEL JR.                                       
JRNL        TITL   SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-1 RECEPTOR           
JRNL        TITL 2 ANTAGONIST PROTEIN.                                          
JRNL        REF    FEBS LETT.                    V. 349    79 1994              
JRNL        REFN                   ISSN 0014-5793                               
JRNL        PMID   8045306                                                      
JRNL        DOI    10.1016/0014-5793(94)00643-1                                 
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   B.J.STOCKMAN,T.A.SCAHILL,A.EUVRARD,N.A.STRAKALAITIS,         
REMARK   1  AUTH 2 D.P.BRUNNER,A.W.YEM,M.R.DEIBEL                               
REMARK   1  TITL   INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN: SOLUTION          
REMARK   1  TITL 2 SECONDARY STRUCTURE FROM NOE'S AND 1H ALPHA AND 13C ALPHA    
REMARK   1  TITL 3 CHEMICAL SHIFTS                                              
REMARK   1  REF    BULL.MAGN.RESON.              V.  14   202 1992              
REMARK   1  REFN                   ISSN 0163-559X                               
REMARK   1 REFERENCE 2                                                          
REMARK   1  AUTH   B.J.STOCKMAN,T.A.SCAHILL,N.A.STRAKALAITIS,D.P.BRUNNER,       
REMARK   1  AUTH 2 A.W.YEM,M.R.DEIBEL                                           
REMARK   1  TITL   PROTON, CARBON AND NITROGEN CHEMICAL SHIFTS ACCURATELY       
REMARK   1  TITL 2 DELINEATE DIFFERENCES AND SIMILARITIES IN SECONDARY          
REMARK   1  TITL 3 STRUCTURE BETWEEN THE HOMOLOGOUS PROTEINS IRAP AND IL-1BETA  
REMARK   1  REF    J.BIOMOL.NMR                  V.   2   591 1992              
REMARK   1  REFN                   ISSN 0925-2738                               
REMARK   1 REFERENCE 3                                                          
REMARK   1  AUTH   B.J.STOCKMAN,T.A.SCAHILL,M.ROY,E.L.ULRICH,N.A.STRAKALAITIS,  
REMARK   1  AUTH 2 D.P.BRUNNER,A.W.YEM,M.R.DEIBEL                               
REMARK   1  TITL   SECONDARY STRUCTURE AND TOPOLOGY OF INTERLEUKIN-1 RECEPTOR   
REMARK   1  TITL 2 ANTAGONIST PROTEIN DETERMINED BY HETERONUCLEAR               
REMARK   1  TITL 3 THREE-DIMENSIONAL NMR SPECTROSCOPY                           
REMARK   1  REF    BIOCHEMISTRY                  V.  31  5237 1992              
REMARK   1  REFN                   ISSN 0006-2960                               
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : DGII                                                 
REMARK   3   AUTHORS     : BIOSYM TECHNOLOGIES, INC.                            
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1IRP COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.                                
REMARK 100 THE DEPOSITION ID IS D_1000174244.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : NULL                               
REMARK 210  PH                             : NULL                               
REMARK 210  IONIC STRENGTH                 : NULL                               
REMARK 210  PRESSURE                       : NULL                               
REMARK 210  SAMPLE CONTENTS                : NULL                               
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : NULL                               
REMARK 210  SPECTROMETER FIELD STRENGTH    : NULL                               
REMARK 210  SPECTROMETER MODEL             : NULL                               
REMARK 210  SPECTROMETER MANUFACTURER      : NULL                               
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : NULL                               
REMARK 210   METHOD USED                   : NULL                               
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : NULL                               
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 12                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : NULL                               
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL                
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
DBREF  1IRP A    2   153  UNP    P18510   IL1RA_HUMAN     26    177             
SEQRES   1 A  153  MET ARG PRO SER GLY ARG LYS SER SER LYS MET GLN ALA          
SEQRES   2 A  153  PHE ARG ILE TRP ASP VAL ASN GLN LYS THR PHE TYR LEU          
SEQRES   3 A  153  ARG ASN ASN GLN LEU VAL ALA GLY TYR LEU GLN GLY PRO          
SEQRES   4 A  153  ASN VAL ASN LEU GLU GLU LYS ILE ASP VAL VAL PRO ILE          
SEQRES   5 A  153  GLU PRO HIS ALA LEU PHE LEU GLY ILE HIS GLY GLY LYS          
SEQRES   6 A  153  MET CYS LEU SER CYS VAL LYS SER GLY ASP GLU THR ARG          
SEQRES   7 A  153  LEU GLN LEU GLU ALA VAL ASN ILE THR ASP LEU SER GLU          
SEQRES   8 A  153  ASN ARG LYS GLN ASP LYS ARG PHE ALA PHE ILE ARG SER          
SEQRES   9 A  153  ASP SER GLY PRO THR THR SER PHE GLU SER ALA ALA CYS          
SEQRES  10 A  153  PRO GLY TRP PHE LEU CYS THR ALA MET GLU ALA ASP GLN          
SEQRES  11 A  153  PRO VAL SER LEU THR ASN MET PRO ASP GLU GLY VAL MET          
SEQRES  12 A  153  VAL THR LYS PHE TYR PHE GLN GLU ASP GLU                      
SHEET    1   A 5 THR A 109  THR A 110  0                                        
SHEET    2   A 5 PHE A 147  GLU A 151 -1  O  PHE A 147   N  THR A 110           
SHEET    3   A 5 ALA A  13  ASP A  18 -1  N  ARG A  15   O  GLN A 150           
SHEET    4   A 5 LYS A  22  LEU A  26 -1  O  LYS A  22   N  ASP A  18           
SHEET    5   A 5 LEU A  31  GLY A  34 -1  N  VAL A  32   O  TYR A  25           
SHEET    1   B 7 THR A 109  THR A 110  0                                        
SHEET    2   B 7 PHE A 147  GLU A 151 -1  O  PHE A 147   N  THR A 110           
SHEET    3   B 7 ALA A  13  ASP A  18 -1  N  ARG A  15   O  GLN A 150           
SHEET    4   B 7 ILE A  47  PRO A  51 -1  O  ILE A  47   N  PHE A  14           
SHEET    5   B 7 LEU A  57  ILE A  61 -1  O  PHE A  58   N  VAL A  50           
SHEET    6   B 7 MET A  66  SER A  73 -1  O  MET A  66   N  ILE A  61           
SHEET    7   B 7 GLU A  76  ALA A  83 -1  O  GLU A  76   N  SER A  73           
SHEET    1   C 4 ALA A 100  ARG A 103  0                                        
SHEET    2   C 4 PHE A 112  ALA A 115 -1  N  GLU A 113   O  ILE A 102           
SHEET    3   C 4 GLY A 119  THR A 124 -1  O  TRP A 120   N  SER A 114           
SHEET    4   C 4 VAL A 132  THR A 135 -1  N  SER A 133   O  CYS A 123           
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000